Karyopharm Therapeutics OverviewKaryopharm Therapeutics Net Income
Profitability analysis for KPTI.
Quarterly Net Income
-$22.39M
↑ 4.56% YoY
As of Mar 2026
Annual Net Income (TTM)
-$194.97M
↓ 211.84% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...